Schedule X medicines require controls beyond those governing ordinary pharmaceutical stock. In West Bengal, businesses intending to sell, stock, exhibit, offer for sale or distribute these medicines must identify the appropriate Schedule X sale licence and satisfy the Drugs Rules, 1945. Retail dispensing also attracts specific prescription, storage and record-retention requirements. Wholesale distribution follows a separate licensing route and supervision framework.
Consequently, an existing ordinary drug-sale permission should never be assumed to authorise Schedule X transactions. Applicants should align their premises, qualified personnel, documentation and stock-control arrangements with the specific permission required before dealing in these medicines.
What Schedule X Classification Means?
Schedule X forms part of the central Drugs Rules, 1945, made under the Drugs and Cosmetics Act, 1940. Therefore, West Bengal does not maintain an independent state-specific list that replaces the central Schedule.
The classification subjects listed substances to additional controls over sale, distribution, prescriptions, storage and records. These requirements aim to maintain traceability and restrict inappropriate access to medicines that receive heightened statutory control.
For a pharmacy or distributor, classification has direct operational consequences. Schedule X stock cannot simply be added to inventory because an establishment already sells prescription medicines. The business must hold the applicable Schedule X permission and follow the conditions governing that licence.
West Bengal’s competent drug-control administration handles state-level sale licensing, scrutiny and enforcement under the central statutory framework. Consequently, applicants must distinguish between the law creating the requirements and the state authority administering those requirements locally.
Schedule X Is Different From Schedules H and H1
Schedules H, H1 and X all impose controls on specified medicines, but they do not represent interchangeable licence categories.
Schedule H medicines generally require retail sale on the prescription of a Registered Medical Practitioner. Schedule H1 adds specific sale-record requirements for listed medicines. Schedule X imposes further controls, including distinct sale licences and special retail storage and prescription-copy requirements.
For Schedule X retail sale, the prescription must be in duplicate, and the licensee must retain one copy for two years. Schedule X substances kept at a retail shop must also satisfy the prescribed secure-storage requirement.
Therefore, holding permission to sell ordinary Schedule H or H1 medicines does not by itself replace the Schedule X-specific licensing requirement.
A business applying for a drug license in West Bengal should consequently identify every category of medicine it intends to handle before assuming that its existing retail or wholesale permission covers additional controlled stock.
Schedule X and NDPS Controls Are Legally Distinct
Schedule X regulation arises under the Drugs and Cosmetics regulatory framework. The Narcotic Drugs and Psychotropic Substances Act, 1985 and its associated rules constitute a separate legal regime.
Therefore, describing every Schedule X medicine simply as a narcotic drug creates an inaccurate legal shortcut. Conversely, the fact that a medicine appears in Schedule X does not establish that Schedule X permission satisfies every requirement that another controlled-substance framework may impose.
Where a substance potentially falls within both regulatory systems, the licensee should assess each framework separately. The applicable permissions, possession controls, documentation and transaction restrictions can arise from different legal provisions.
A pharmacy or distributor should consequently verify the legal status of the particular substance rather than relying only on its commercial product category.
Retail and Wholesale Schedule X Permissions Differ
The intended transaction determines which Schedule X sale licence the applicant requires.
Retail activity involves supplying medicines to patients or consumers in accordance with applicable prescription requirements. Wholesale activity involves sale or distribution through the authorised wholesale channel rather than ordinary dispensing directly to consumers.
Under the Drugs Rules, Schedule X retail and wholesale licences are separate:
- Form 20F applies to retail sale of Schedule X drugs.
- Form 20G applies to wholesale sale of Schedule X drugs.
- Form 19C serves as the application for a licence to sell, stock, exhibit, offer for sale or distribute Schedule X drugs, with the applicant indicating retail or wholesale activity as applicable.
A business conducting both forms of activity must ensure that its permissions correspond with both operations. A wholesale licence should not be treated as unrestricted authority for retail dispensing.
Separate premises can also matter. Where drugs are sold or stocked for sale at more than one place, the Drugs Rules generally require separate applications and licences for each location.
Personnel Requirements Depend on the Licence
Technical supervision requires particular attention because retail and wholesale arrangements should not be treated as identical.
Form 20F concerns retail sale of Schedule X drugs. The Drugs Rules provide that this licence is granted only to a pharmacy, except that in an area where a pharmacy does not operate, the licensing authority may grant it to a chemist and druggist. Pharmacy requirements therefore affect the retail route.
For wholesale Schedule X operations, Form 20G addresses wholesale sale. A 2026 amendment expressly requires sale under the personal supervision of a competent person and requires the licence to identify that person.
The same amendment requires a Form 20G licensee to report a change in the competent person to the licensing authority within one month.
Accordingly, applicants should not use “registered pharmacist” and “competent person” as interchangeable descriptions. They should establish which personnel standard applies to their proposed activity and provide evidence supporting the nominated person’s eligibility.
Premises Must Support the Licensed Operation
Before granting Forms 20F or 20G, the licensing authority must satisfy itself that the premises are adequate and contain proper storage accommodation capable of preserving the properties of the drugs.
The Drugs Rules also connect retail pharmacy licensing with Schedule N requirements. Therefore, applicants proposing Schedule X retail operations should assess the premises as a pharmacy rather than viewing them merely as commercial space.
Premises documentation can vary according to ownership, tenancy and administrative requirements. Applicants should normally be ready to establish lawful possession and identify the exact location proposed for licensing.
Where retail and wholesale operations coexist, the applicant should also confirm the premises conditions applicable to the combined arrangement. Minimum-area requirements under the drug-sale framework depend on the licences and activities sought, so applicants should verify the current requirement against their proposed combination before finalising a property.
Schedule X Retail Stock Requires Secure Storage
Secure storage creates one of the clearest distinctions between Schedule X retail stock and ordinary pharmacy inventory.
The Drugs Rules require Schedule X substances kept in a retail shop or connected premises to be stored either:
- under lock and key in a cupboard or drawer reserved solely for those substances; or
- in a part of the premises separated from the remainder and accessible only to responsible persons.
This requirement concerns access security. It does not replace product-specific storage conditions. If a manufacturer’s approved labelling requires a particular temperature or other environmental condition, the pharmacy must preserve the medicine accordingly.
Operationally, access should remain restricted to responsible personnel. Stock organisation should also allow the licensee to identify Schedule X inventory and reconcile physical quantities with purchase and sale documentation.
A general locked cupboard containing unrelated goods would not reflect the first statutory storage option, which reserves the cupboard or drawer solely for Schedule X substances.
Documents Should Match the Applicant and Activity
The precise supporting documents can vary with the constitution of the business and West Bengal’s administrative application requirements. Nevertheless, applicants should organise documentation around the statutory licence and the facts the authority must verify.
Relevant documentation can include:
- completed Form 19C and prescribed application details;
- identity and address evidence for applicants or authorised persons;
- proprietorship, partnership, LLP or company constitution records, as applicable;
- premises ownership or tenancy evidence;
- premises layout or site information where requested;
- details of storage arrangements;
- pharmacist documentation for the retail pharmacy route;
- competent-person documentation for wholesale operations;
- appointment or employment evidence for responsible personnel;
- existing drug-sale licence details where relevant; and
- proof of payment of the prescribed government fee.
Corporate applicants may also need authorisation identifying the person permitted to sign and act for the entity.
Applicants should distinguish documents expressly required by the statutory framework from supporting records requested through the state’s administrative process. They should not create affidavits or no-objection certificates merely because an unrelated licensing application required them.
Application Process in West Bengal
The licensing journey should begin with activity classification rather than document submission.
A practical sequence involves:
- Decide whether the establishment will undertake retail sale, wholesale distribution or both.
- Confirm that the proposed premises satisfy the relevant drug-sale and pharmacy conditions.
- Appoint the registered pharmacist or competent person required for the applicable activity.
- Establish secure Schedule X storage arrangements.
- Prepare Form 19C and supporting business, premises and personnel documents.
- Pay the prescribed statutory fee through the applicable process.
- Submit the application to the competent West Bengal licensing authority.
- Address documentary queries or deficiencies raised during scrutiny.
- Make the premises and proposed arrangements available for regulatory inspection where required.
- Commence Schedule X transactions only after receiving the appropriate licence and satisfying its conditions.
Submission does not create permission to trade. The licensing authority must find that applicable statutory conditions have been satisfied before granting the licence.
Inspection Tests Operational Readiness
Inspection allows the drug-control administration to assess whether the proposed premises and arrangements correspond with the application and statutory requirements.
Depending on the application, an inspecting officer may examine premises suitability, pharmacy arrangements, storage accommodation, Schedule X security, personnel documentation and records intended for controlled stock.
The officer can also verify whether the technical person identified in the application genuinely supervises the relevant operation and whether storage arrangements preserve the properties of medicines.
Applicants should therefore prepare the establishment for actual operations rather than treating inspection as a document-verification exercise.
After licensing, inspectors can require production of registers and records maintained under the Drugs Rules and request information necessary to determine whether the Act and Rules have been observed.
Retail Dispensing Requires a Controlled Prescription Process
Schedule X medicines cannot be sold by retail except on and in accordance with a prescription from a Registered Medical Practitioner.
The prescription must be in duplicate for Schedule X substances. The retailer must retain one copy for two years.
For the applicable prescription requirement, the written prescription must carry the prescriber’s signature and date, identify the patient by name and address, or identify the animal’s owner where the medicine is intended for veterinary use, and state the total quantity to be supplied and dose.
Dispensing also carries further restrictions. A prescription must not be dispensed more than once unless the prescriber expressly permits repeat dispensing. Where the prescriber specifies the number of supplies or intervals, dispensing must follow those directions.
At dispensing, the seller’s name and address and the dispensing date must be noted on the prescription as required. The dispenser cannot substitute another preparation in lieu of the prescribed Schedule X preparation.
Records Must Make Schedule X Stock Traceable
Prescription retention represents only one part of record control. Licensees must also maintain the purchase and sale records required under the Drugs Rules and licence conditions.
The records should allow an inspector to trace stock entering and leaving the establishment. Depending on the transaction, relevant information can include the drug, quantity, date, supplier or purchaser, prescription or written order and supporting invoice.
The Drugs Rules generally require registers and records maintained under the relevant provisions to be preserved for at least two years from the date of the last entry unless another provision specifies otherwise.
Supply of Schedule X drugs to Registered Medical Practitioners, hospitals, dispensaries and nursing homes requires a signed written order, which the licensee must preserve for two years.
Accordingly, a pharmacy should not confuse retained prescription copies with its broader purchase, sale and stock documentation.
Wholesale Supply Requires Controlled Distribution
Form 20G authorises the applicable wholesale Schedule X activity; it does not create unrestricted authority to dispense directly to consumers.
Wholesale operators should supply through legally permitted channels and maintain transaction records capable of establishing the identity of purchasers, medicines supplied, quantities and dates.
Before supplying another business or institution, the wholesaler should verify that the recipient can lawfully receive the medicines concerned. Invoices and written orders should correspond with the physical movement of stock.
Procurement deserves equal scrutiny. Schedule X medicines should enter inventory through lawful, traceable sources supported by appropriate invoices and supplier information.
Batch details and other product information should remain available through normal pharmaceutical stock documentation where applicable. These controls allow the business to establish the source and destination of medicines when an inspector examines a transaction.
Stock Reconciliation Should Identify Every Movement
Physical Schedule X stock should correspond with documented receipts and supplies.
A practical reconciliation process should account for:
- opening quantity;
- purchases received;
- retail or wholesale supplies;
- authorised returns;
- damaged or unusable stock;
- expired stock; and
- closing physical balance.
A discrepancy does not by itself establish one predetermined regulatory consequence. However, unexplained differences can raise serious questions because Schedule X controls depend heavily on traceability.
Expired, damaged or returned medicines should remain protected against accidental resale or unauthorised access. Businesses should segregate such stock appropriately and document its status.
Any return to a supplier or disposal should follow the legally applicable procedure and preserve an auditable record. Licensees should not invent their own destruction process for controlled stock where another statutory framework or authorised procedure applies to the substance.
Schedule X Duties Continue After Licence Grant
Receiving Form 20F or Form 20G starts continuing obligations. The licensee must maintain the premises, storage, personnel and records required for the authorised activity.
Key controls include:
- conducting only activities covered by the licence;
- maintaining qualified technical supervision;
- securing Schedule X retail stock as prescribed;
- dispensing retail stock only against compliant prescriptions;
- retaining required prescription copies and written orders;
- maintaining traceable purchase and sale documentation;
- producing records when lawfully required by an inspector; and
- keeping licensing particulars current where changes require regulatory action.
For Form 20G, the current rules specifically require reporting a change in competent person within one month.
A retail establishment should likewise address a pharmacist’s departure promptly because operations requiring pharmacist supervision cannot simply continue indefinitely without the required qualified person.
Premises and Constitution Changes Need Review
A drug-sale licence relates to the licensed establishment and the approved business circumstances. Therefore, moving Schedule X stock to a new shop should not be treated as a simple internal address update.
The Drugs Rules require separate licensing for separate places of sale or stock. A proposed relocation should consequently be addressed through the applicable licensing procedure before controlled operations shift premises.
Changes in ownership or business constitution can also affect the licence. A proprietorship becoming a partnership, admission or departure of partners, corporate restructuring, or another material constitutional change may trigger regulatory requirements under the drug-licensing framework.
Changes involving the business name, authorised signatory or responsible technical personnel should similarly be checked against current notification or amendment requirements.
The safest operational principle is to obtain the required regulatory treatment before relying on an existing Schedule X permission after a material change.
Licence Retention Replaced the Old Renewal Assumption
Current drug-sale licensing rules should not be described using the older assumption that every licence simply expires after five years and requires conventional renewal.
Forms 20F and 20G remain valid subject to the licence-retention mechanism, unless suspended or cancelled. The licensee must deposit the prescribed licence-retention fee before the expiry of each succeeding five-year period from the licence’s issue.
The retention fee equals the respective fee prescribed for grant of the licence. Current rules also provide a limited late-payment mechanism with an additional fee; failure to comply within the permitted period can affect continuation of the licence.
Therefore, businesses should calendar the applicable retention date and separately monitor changes that require amendments, fresh applications or regulatory notification.
Common Compliance Failures Create Regulatory Risk
Schedule X compliance problems frequently arise from operational conduct rather than the initial application.
Selling without the appropriate Schedule X permission directly undermines the licensing framework. Dispensing without the prescribed duplicate prescription, failing to retain the required copy, allowing unauthorised access to controlled stock or maintaining incomplete transaction records can also create regulatory exposure.
Wholesale businesses face similar concerns if they cannot establish lawful recipients or account for stock movements.
Another risk arises when the technical person leaves but the business continues regulated operations without addressing the personnel requirement. Likewise, moving premises or changing the business constitution without checking licensing consequences can create a mismatch between the licence and actual establishment.
Regulatory consequences depend on the particular breach, statutory provision, evidence and action taken by the competent authority. Therefore, businesses should not assume that every deficiency produces the same penalty or automatically causes cancellation.
Pre-Application Checklist
Before seeking Schedule X permission in West Bengal, verify:
- whether transactions will be retail, wholesale or both;
- whether Form 20F, Form 20G or both are required;
- use of the correct Form 19C application route;
- legal constitution of the applicant;
- suitability of the proposed premises;
- applicable pharmacy requirements;
- registered pharmacist arrangements for retail operations;
- competent-person arrangements for wholesale operations;
- secure Schedule X storage;
- product-specific storage conditions;
- business and premises documents;
- personnel qualification and appointment records;
- prescribed application fee;
- readiness for regulatory scrutiny or inspection;
- duplicate-prescription handling procedures;
- prescription and written-order retention;
- purchase and sale record systems;
- stock reconciliation procedures; and
- arrangements for expired, damaged and returned stock.
These checks should be completed before purchasing Schedule X inventory for commercial sale.
Conclusion
Schedule X licensing in West Bengal requires more than ordinary drug-sale registration. The operator must match retail or wholesale activity with the correct permission, maintain suitable premises and qualified personnel, secure controlled stock, follow prescription restrictions and preserve traceable transaction records. Post-licensing inspections, personnel changes, premises changes and licence-retention obligations also require continuing attention.
Before stocking any Schedule X medicine, a business should verify its current classification and every regulatory framework applicable to that substance rather than relying solely on an existing pharmacy or wholesale permission.
FAQs
1. Does an ordinary retail drug licence cover Schedule X medicines?
No. The Drugs Rules prescribe a separate Schedule X retail licence in Form 20F. A pharmacy that already holds ordinary retail permissions should therefore confirm and obtain the applicable Schedule X authorisation before stocking or selling these medicines. Existing authority for Schedule H or H1 medicines does not replace Form 20F.
2. Which licence applies to wholesale Schedule X medicines?
Form 20G applies to wholesale sale of drugs specified in Schedule X. The application route uses Form 19C for the relevant Schedule X sale permission. Wholesale operations must also satisfy applicable premises, storage, supervision and record requirements rather than relying solely on an ordinary wholesale drug-sale licence.
3. Does Schedule X retail sale require a registered pharmacist?
Form 20F applies to the retail Schedule X route and is ordinarily granted only to a pharmacy, subject to the limited provision concerning areas where a pharmacy does not operate. Applicants should therefore satisfy the applicable pharmacy and professional-supervision requirements before seeking permission to dispense Schedule X medicines.
4. Who supervises wholesale Schedule X sales?
Current Form 20G conditions require wholesale sale under the personal supervision of a competent person. The licence identifies that competent person. Following the 2026 amendment, a Form 20G licensee must also report a change in the competent person to the licensing authority within one month of that change.
5. Is a prescription required for Schedule X retail sale?
Yes. Retail sale must occur on and in accordance with a prescription from a Registered Medical Practitioner. For Schedule X medicines, the prescription must be in duplicate. The prescription must also contain the prescribed particulars, including patient information, quantity and dose, and comply with applicable repeat-dispensing restrictions.
6. How long must a Schedule X prescription copy be retained?
The licensee must retain one copy of the duplicate Schedule X prescription for two years. Additionally, signed written orders covering supplies to Registered Medical Practitioners, hospitals, dispensaries and nursing homes must be preserved for two years. These records should remain readily retrievable during regulatory inspection.
7. How must Schedule X medicines be stored at retail premises?
Retail Schedule X substances must remain under lock and key in a cupboard or drawer reserved solely for them, or in a separated part of the premises accessible only to responsible persons. Product-specific temperature and environmental storage requirements must also be followed where the medicine’s approved conditions require them.
8. Do Schedule X sale records need to be preserved?
Yes. Applicable registers and records must be maintained in accordance with the Drugs Rules and licence conditions. Unless another provision specifies otherwise, records maintained under the Rules generally require preservation for at least two years from the last entry. Prescription-copy requirements operate alongside these broader transaction records.
9. Do Schedule X sale licences require renewal every five years?
The current framework uses a licence-retention mechanism rather than the older conventional renewal model. Forms 20F and 20G remain valid unless suspended or cancelled, provided the licensee deposits the prescribed retention fee before each succeeding five-year period and satisfies the applicable retention provisions.
10. Does a Schedule X licence satisfy NDPS requirements?
Not automatically. Schedule X belongs to the Drugs and Cosmetics regulatory framework, while the NDPS Act and associated rules form a separate control system. If a substance attracts requirements under both regimes, the operator must assess each independently. Schedule X permission does not displace another legally applicable authorisation or control.
